Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Netherlands

Netherlands Articles

Industry

BMI View: Drug companies will face many challenges in Western Europe over the next decade. Our forecast is underpinned by the poor state of public finances across the eurozone, which... 2011-04-19


Industry

BMI View: Despite the threat of austerity measures, the government's focus on cost-containment within the pharmaceuticals and healthcare sector and the impact of generic competition... 2011-04-18


Industry

BMI Core View: The uptake of generic drugs following patent expiries will become swifter. This trend will reduce costs for governments, out-of-pocket payers and insurance companies,... 2011-02-16


More ARTICLES

Industry

BMI View: Deficits remain a key challenge for the majority of governments across Europe. While many industries may see only limited downside risks from the situation, the pharmaceuticals... 2010-10-21


Industry

Despite a compound annual growth rate (CAGR) of 3.61% in local currency terms and of 6.1% in US dollar terms from 2004-2009, BMI's outlook for the Netherlands' patented drug market... 2010-01-19


Industry

Multinational company Philips Electronics has signed a deal with the largest health insurer in the Netherlands, Achmea (which has approximately a 30% share of the Dutch health insurance... 2009-11-06


Industry

Global logistics firm UPS has opened two new facilities in Roermond, the Netherlands, and San Juan, Puerto Rico, dedicated to the storage and transport of medical devices and pharmaceutical... 2009-10-12


Industry

Germany based pharmaceutical wholesale giant Celesio has written down the book value of pharmacies in its small European markets for the second time this year, and is looking to stop... 2009-10-09

Western Europe InsightWestern Europe Channels Western Europe Countries